Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

6 Dec 2013 17:46

RNS Number : 9748U
Ark Therapeutics Group PLC
06 December 2013
 



BLOCK LISTING SIX MONTHLY RETURN

 

Date: 6 December 2013

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Unapproved Share Option Scheme

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

2,271,252

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

2,271,252

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

939,433

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

939,433

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group 2005 Long Term Incentive Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

683,200

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

683,200

 

Name of applicant:

Ark Therapeutics Group plc

Name of scheme:

Ark Therapeutics Group Approved Share Option Plan

Period of return:

From:

03/06/2013

To:

02/12/2013

Balance of unallotted securities under scheme from previous return:

1,000,000

Plus: The amount by which the block scheme has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme during period:

NIL

Equals: Balance under scheme not yet issued/allotted at end of period:

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 002 1005

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRDMMGZNVDGFZM
Date   Source Headline
6th Sep 20134:40 pmRNSSecond Price Monitoring Extn
6th Sep 20134:35 pmRNSPrice Monitoring Extension
6th Sep 201312:54 pmRNSHolding(s) in Company
4th Sep 20134:40 pmRNSSecond Price Monitoring Extn
4th Sep 20134:35 pmRNSPrice Monitoring Extension
2nd Sep 201312:00 pmRNSHolding(s) in Company
29th Aug 20134:41 pmRNSSecond Price Monitoring Extn
29th Aug 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20139:00 amRNSHalf Yearly Report
16th Aug 20134:40 pmRNSSecond Price Monitoring Extn
16th Aug 20134:35 pmRNSPrice Monitoring Extension
15th Aug 20135:32 pmRNSHolding(s) in Company
14th Aug 20134:56 pmRNSHolding(s) in Company
30th Jul 20134:40 pmRNSSecond Price Monitoring Extn
30th Jul 20134:35 pmRNSPrice Monitoring Extension
23rd Jul 20133:44 pmRNSHolding(s) in Company
9th Jul 20132:00 pmRNSCompany Update
8th Jul 20134:40 pmRNSSecond Price Monitoring Extn
8th Jul 20134:35 pmRNSPrice Monitoring Extension
5th Jul 201310:48 amRNSHolding(s) in Company
5th Jul 20137:00 amRNSCompany Update
27th Jun 20134:40 pmRNSSecond Price Monitoring Extn
27th Jun 20134:35 pmRNSPrice Monitoring Extension
25th Jun 20132:05 pmRNSResults of Annual General Meeting
14th Jun 20134:40 pmRNSSecond Price Monitoring Extn
14th Jun 20134:35 pmRNSPrice Monitoring Extension
4th Jun 20132:48 pmRNSBlocklisting Six Monthly Return
24th May 20134:40 pmRNSSecond Price Monitoring Extn
24th May 20134:35 pmRNSPrice Monitoring Extension
17th May 20137:00 amRNSInterim Management Statement
16th May 20131:20 pmRNSHolding(s) in Company
8th May 20136:09 pmRNSHolding(s) in Company
8th May 20135:47 pmRNSHolding(s) in Company
2nd May 20131:45 pmRNSHolding(s) in Company
1st May 20134:35 pmRNSPrice Monitoring Extension
30th Apr 20137:00 amRNSFinal Results
26th Apr 20134:50 pmRNSHolding(s) in Company
24th Apr 20133:47 pmRNSHolding(s) in Company
26th Mar 20134:40 pmRNSSecond Price Monitoring Extn
26th Mar 20134:35 pmRNSPrice Monitoring Extension
22nd Mar 201311:50 amRNSHolding(s) in Company
20th Mar 20131:15 pmRNSHolding(s) in Company
19th Mar 201311:34 amRNSForm 8.3 - Ark Therapeutics
19th Mar 20139:47 amRNSHolding(s) in Company
18th Mar 20131:54 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Mar 201312:01 pmRNSTermination of Offer Period and Rule 10.8 Waiver
7th Mar 20134:22 pmRNSForm 8.3 - [Ark Therapeutics Group]
6th Mar 20133:04 pmRNSForm 8.3 - [Ark Therapeutics Group]
6th Mar 201310:02 amRNSForm 8.3 - Ark Therapeutics Group Plc
1st Mar 201311:49 amRNSForm 8.3 - Ark Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.